Why are Americans shouldering the burden of paying for drug innovations?
Antimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.
Technology can help reduce error rates in IV compounding.
How can we better engage patients for greater adherence rates?
Maybe the health-care industry could learn something from Pete Kreckel's mother.
It isn't the number of prescriptions that makes a good day in the pharmacy, it is the staffing.
A pharmacist looks back at what he was told in pharmacy school.
Pete Kreckel has a love hate relationship with technology.
Because of the NECC Case, the nation has a much more consistent approach toward regulating and overseeing compounding pharmacies.
AACP offers a rebuttal to a Drug Topics opinion article.